Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia

Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is an aggressive heterogeneous blood cancer derived from hematopoietic stem cells. Tumor-stromal interactions in AML are of importance for disease development and therapy resistance, and bone marrow stroma seem like an attractive therapeutic target. Of particular interes...

Full description

Bibliographic Details
Main Authors: Kristine Yttersian Sletta, Oriol Castells, Bjørn Tore Gjertsen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
colony stimulating factor 1 receptor
tumor-stroma
signal transduction
biomarkers
acute myeloid leukemia
targeted therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.654817/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.654817/full

Similar Items